A major UK trial is testing whether computer-assisted detection (CADe) truly transforms colonoscopy outcomes in everyday practice. Interim results from…
Browsing: Clinical Updates
The FDA has approved guselkumab (Tremfya, J&J) as the first IL-23 inhibitor available in both subcutaneous (SC) and IV induction…
GI care is undergoing a quiet revolution. Once dismissed as psychosomatic, conditions like IBS and SIBO are now being reframed…
Too often, patients with bloating, abdominal pain, or persistent bowel issues wait years before reaching the right diagnosis. But new…
In a stunning first, German researchers report that a young woman with multidrug-resistant ulcerative colitis entered complete remission after receiving…
The World Gastroenterology Organisation has introduced a new “Global Cascade Approach” to managing chronic constipation—one of the most common yet…
The American Gastroenterological Association has issued new clinical guidance on gastroparesis, emphasizing a personalized, patient-centered approach over rigid treatment pathways.…
Infants delivered by C-section are known to carry a distinct gut microbiome that increases their risk of allergies, asthma, and…
The gut-skin axis (GSA) is emerging as a key player in linking gastrointestinal health to dermatological diseases through immune, metabolic,…
Guardant Health and Quest Diagnostics have struck a multi-year deal to make Shield™, the first FDA-approved blood test for colorectal…